Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Toxic glomerulonephritis].

P Druet1, D Kleinknecht

  • 1INSERM U28, Hôpital Broussais, Paris.

Presse Medicale (Paris, France : 1983)
|November 11, 1989
PubMed
Summary
This summary is machine-generated.

Most kidney diseases involve immune responses, with antibodies playing a key role in their development. Certain toxins and drugs can trigger these immune-mediated glomerulopathies, leading to kidney damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mercuric chloride-induced autoimmunity.

Current protocols in immunology·2008
Same author

The immunosuppressant LF 15-0195 prevents experimental autoimmune myasthenia gravis in Brown-Norway rats.

Transplantation proceedings·2002
Same author

Beneficial effect of the immunosuppressant LF 15-0195 on passively induced rat experimental autoimmune encephalomyelitis.

Transplantation proceedings·2002
Same author

Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases.

Immunological reviews·2002
Same author

[Calcium-dependent pathways involved in the production of cytokines in lymphocytes].

Journal de la Societe de biologie·2002
Same author

Self major histocompatibility complex class-II-specific regulatory CD4 T cells prevent both Th1- and Th2-mediated autoimmune diseases in the rat.

Microbes and infection·2001
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Immunology
  • Nephrology
  • Pathogenesis of Glomerulopathies

Context:

  • Glomerulopathies are primarily immune-mediated kidney diseases.
  • Understanding the pathogenesis of these conditions is evolving.
  • Recent research highlights the significant role of cell-mediated immunity and circulating antibodies.

Purpose:

  • To elucidate the immunological mechanisms underlying glomerulopathies.
  • To explore the role of antibodies, including self-antigens and planted antigens.
  • To investigate the impact of toxins and drugs on immune glomerulopathy development.

Summary:

  • Circulating antibodies are increasingly recognized as crucial in glomerulopathy pathogenesis, potentially targeting structural or non-renal 'planted' antigens.
  • Exposure to toxins (heavy metals, certain drugs) can induce immune glomerulopathies via T lymphocyte activation and autoantibody production.

Related Experiment Videos

  • Direct drug toxicity (e.g., doxorubicin, mitomycin) and drug addiction can also cause distinct glomerular lesions and glomerulosclerosis.

    • Impact:

    • Provides a deeper understanding of immune-mediated kidney disease mechanisms.
    • Identifies potential triggers for glomerulopathies, aiding in diagnosis and prevention.
    • Highlights the diverse ways drugs and toxins impact renal health.